Farmako ApS: Financial statements 2022
CVR: 40143548
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Farmako ApS (CVR 40143548) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,500 and a net result of DKK -13,500 compared with DKK -13,125 the year before. Equity in the 2022 report amounted to DKK -32,529.
- Gross Profit
- DKK -13,500
- Profit/Loss
- DKK -13,500
- Equity
- DKK -32,529
- Total Assets
- DKK 6,847
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -14 t. | -14 t. | -33 t. | - |
| 2021 | - | -13 t. | -13 t. | -19 t. | - |
| 2020 | - | -27 t. | -27 t. | -6 t. | - |
| 2019 | - | -29 t. | -29 t. | 21 t. | - |
Official annual report
Keep an eye on Farmako ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Farmako ApS has published its annual report for 2021. Gross profit came to DKK -13,125, and the net result was DKK -13,125.
About Farmako ApS
Farmako ApS was a Danish company of the type Anpartsselskab based in København V, founded in 2019. The company has been dissolved on 19 June 2026. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2024, the company reported a gross profit of DKK -15,750 and a net result of DKK -15,749 compared with DKK -16,875 the year before. Equity in the 2024 report amounted to DKK -65,153.